LANTHEUS HOLDINGS INC. - COMMON STOCK

NetDania - New 12 months High: LANTHEUS HOLDINGS INC. - COMMON STOCK

11 7月 2024 08:45:04 条件 NetDania Notify

Lantheus Welcomes CMS’ Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access

10 7月 2024 11:32:21 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: LANTHEUS HOLDINGS INC. - COMMON STOCK

10 7月 2024 08:45:28 条件 NetDania Notify

Lantheus Appoints Jamie Spaeth as Chief People Officer

08 7月 2024 07:30:00 条件 Nasdaq GlobeNewswire

Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers

27 6月 2024 06:05:00 条件 Nasdaq GlobeNewswire

Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform

03 6月 2024 07:30:00 条件 Nasdaq GlobeNewswire

Lantheus to Present at the William Blair 44th Annual Growth Stock Conference

28 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Lantheus Announces Executive Appointments to Accelerate Innovation

15 5月 2024 15:30:00 条件 Nasdaq GlobeNewswire

Lantheus Reports First Quarter 2024 Financial Results

02 5月 2024 06:00:01 条件 Nasdaq GlobeNewswire

Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time

18 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024

05 3月 2024 07:30:00 条件 Nasdaq GlobeNewswire

Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients

04 3月 2024 07:30:00 条件 Nasdaq GlobeNewswire

Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer

28 2月 2024 07:30:00 条件 Nasdaq GlobeNewswire

Lantheus to Present at the TD Cowen 44th Annual Health Care Conference

26 2月 2024 07:30:00 条件 Nasdaq GlobeNewswire

Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results

22 2月 2024 06:00:00 条件 Nasdaq GlobeNewswire

Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging

13 2月 2024 07:30:00 条件 Nasdaq GlobeNewswire

Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time

08 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Lantheus Announces CEO Succession Plan

23 1月 2024 06:45:00 条件 Nasdaq GlobeNewswire

Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate)

11 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics

09 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire